All Posts: cancer
-
Months After Chemotherapy, MD/PhD Student Bikes 50 Miles for Cancer Research
A year and a half into medical school at Georgetown, Bryan Weselman was diagnosed with cancer. Now, he’s researching cancer to improve treatment for other patients.
Category: GUMC Stories
-
ISPY2: A Unique, Flexible Breast Cancer Trial for Modern Times
The ISPY2 breast cancer clinical trial is a unique phase 2 study that offers a broad range of treatment options for patients with locally advanced breast cancer.
Category: GUMC Stories
-
Georgetown Global Health and Cancer Researchers Tackle Public Health Challenge in Eswatini
A collaboration between researchers at Georgetown’s Lombardi Comprehensive Cancer Center and a Georgetown global health team in Eswatini aims to address a significant public health challenge: preventing cervical cancer.
Category: GUMC Stories
-
Addressing Cancer Screening Behaviors in the Muslim Community in Washington
An important study has revealed crucial insights into the cancer screening behaviors of Muslims in the Washington, D.C., area, highlighting the influence of cultural and religious beliefs on health practices.
Category: News Release
-
Case Study Reveals Important New Details About Rare Second Cancers Related to CAR-T Therapy
A new, detailed analysis of a patient’s second cancer after receiving CAR-T therapy for the initial cancer provides rare but important insights intended to offer helpful guidance for oncologists and pathologists about the clinical presentation and pathologic features involved in a CAR-T related second cancer.
Category: News Release
-
Experimental Therapy Shows Promise in Pancreatic Cancer Clinical Trial
Clinicians at Georgetown University’s Lombardi Comprehensive Cancer Center reported promising preliminary findings based on outcomes in the first six patients with metastatic pancreatic cancer enrolled in a phase 2 clinical trial of the experimental drug BXCL701 in combination with the immunotherapy drug pembrolizumab (Keytruda). Immunotherapy drugs alone have not shown to be responsive to pancreatic cancer.
Category: News Release
-
The Aspirin Conundrum: Navigating Negative Results, Age, Aging Dynamics and Equity
A new study examining the role of aspirin in breast cancer treatment reveals critical issues related to health equity and aging that have broad implications for cancer and other disease intervention trials, say researchers from Georgetown University’s Lombardi Comprehensive Cancer Center. They outline their concerns in an editorial accompanying the study’s findings published April 29 in the JAMA.
Category: News Release
-
Psychosocial Oncology Program Promotes Cura Personalis in Cancer Care
As director of the psychosocial oncology program at Georgetown Lombardi, Kimberly M. Davis, PhD, supports the psychological needs of cancer patients, while also training future independent clinical researchers in the field.
Category: GUMC Stories
-
Could a Georgetown Lab Finding Lead to New Treatment in Pancreatic Cancer?
For the first time, new research by Georgetown scientists shows potential to make immunotherapy effective in pancreatic cancer by combining it with a drug that makes cancer cells more responsive to immunotherapy.
Category: GUMC Stories
-
Understanding Immunotherapy Resistance Leads to New Therapeutic Strategies — and Hope
Samir Khleif, MD, an immunologist and professor of oncology at Georgetown Lombardi, is working to understand why some cancers become resistant to immunotherapy, and how that resistance can be overcome.
Category: GUMC Stories